872677-70-8

Upstream product

• 18929-63-0 methyl 4,6-O-para-methoxybenzylidene-α-D-glucopyranoside 
• 97-30-3 methyl-alpha-D-glucopyranoside 
• 2186-92-7 p-Anisaldehyde dimethyl acetal 
• 637774-19-7 methyl 4-O-(4-methoxybenzyl)-2,3-di-O-tetradecyl-α-D-glucopyranoside 
• 872677-66-2 methyl 4-O-(4-methoxybenzyl)-2,3-di-O-tetradecyl-α-D-gluco-hexodialdo-1,5-pyranose-6-O-methyloxime 
• 637774-18-6 methyl 4,6-O-(4-methoxybenzylidene)-2,3-di-O-tetradecyl-α-D-glucopyranoside 
• 872677-65-1 methyl 4-O-(4-methoxybenzyl)-2,3-di-O-tetradecyl-α-D-gluco-hexodialdo-1,5-pyranoside 
• 637774-23-3 4,6-di-O-acetyl-2,3-di-O-tetradecyl-α-D-glucopyranosyl bromide 
• 872677-67-3 methyl 6-methoxyamino-4-O-(4-methoxybenzyl)-2,3-di-O-tetradecyl-6-deoxy-α-D-glucopyranoside 

Relevant academic research and scientific papers

Synthesis and biological evaluation of novel lipid A antagonists

A mimetic of Lipid A with a β-N(OMe) glycosidic linkage, four linear C-14 hydrophobic chains and without phosphate groups has been prepared together with its β-O-linked analogue. Both these molecules were active in inhibiting the inflammatory action of Es